The company alerted U.S. customers Tuesday that the vaccine can lose potency over time and fail to adequately protect against some strains of the flu. The Flulaval Quadrivalent Thimerosal-free vaccine in prefilled syringes is designed to protect against four strains of influenza virus.
GlaxoSmithKline recalls 1.7 million flu vaccines because they can lose potency over time
by Research Team | Apr 18, 2015 | Health News | 0 comments